Bidiferon medicine for preventive treatment iron and folic acid (10 blisters x 10 tablets)

Dosage form Film bag tablets
Specifications Box of 10 blisters x 10 tablets
Ingredient Folic Acid, Iron
Indication Iron anemia

Ingredient

Thành phần cho 1 viên

Composition informationContent
Folic Acid0.35mg
Iron50mg

Uses

Indications

Bidiferon 160.2 mg Bidiphar 10x10 is indicated for iron deficiency and folic acid prophylaxis during pregnancy when food does not provide sufficient amounts. It is not used in preventing abnormal risks of embryo neural tube. Bidiferon can be used in pregnant women.

Pharmacokology

Pharmacological group: Vitamins and minerals.

Code ATC: B03AD03

Pharmacological and mechanism of action:

related to iron

Mechanism of action: iron is the central atom of heme, constituent hemoglobin and is also essential for red blood cell creation.

Pharmacological effects: iron is distinguished from other minerals: Due to the absence of physiological excretion mechanism, the equilibrium state of iron in the human body is regulated by iron absorption. The absorption of sulfate iron (FeSO) is carried out by iron transportation (DMT) at the tip of the small intestine (duodenum and near the rosary).

related to folic acid

Mechanism of action: Folic acid (folat) acts as a coenzyme in transporting carbon atoms from the biosynthesis of nucleotides purine and Devothymidic acids needed for DNA and RNA synthesis. In general, the growth and multiplication of cells requires high amounts of folic acid: like the tissues of the nervous system and red blood cells.

Pharmacological effects: The human body cannot synthesize folic acid, so the amount of folic acid input is mainly from the diet. Folic acid has the ability to absorb faster in the intestine because of higher than natural folat.

Safety and clinical effectiveness: A single, random clinical test with 131 pregnant women has been conducted to assess the effects of iron and folic acid on pregnant women's biological indicators. This study showed that the addition of iron and folic acid limits the decline in biological criteria of plasma plasma hemoglobin and plasma ferritin) and folic acid (folat red blood cells and serum folat) at birth.

pharmacokinetic pharmacokinetics

related to iron

absorption

iron absorption is a process that is mainly located in the duodenum and near the rosary. The combination of iron sulfate and excipients allows continuous release of iron. Increased absorption when iron reserves decreased.

iron absorption may be changed by simultaneous use of certain foods, drinks or sharing some drugs (see warning and caution and interaction, cavalry of the drug).

Distribution

In the body, iron reserves are mainly found in the bone marrow (pink blood cells), red blood cells, liver and spleen. In the blood, iron is transported mainly by transferin to the bone marrow, where it is combined into hemoglobin.

Metabolism

iron is a metal ion, not metabolized through the liver.

Elimination

The main excretion of the gastrointestinal tract (peeling of the intestinal cell, the recession of heme leads to the drainage of red blood cells), the urinary tract and the skin.

related to folic acid

absorption

Folic acid (folat) is quickly absorbed into the digestive tract, mainly at the tip of the small intestine.

Distribution

Folat is distributed throughout the body. The main storage place of folat is the liver. They also focus on cerebrospinal fluid. Folat is also excreted in breast milk.

Metabolism

Folat is transformed into an active metabolic form: 5-methyllahydrofolate (5MTHF) in plasma and liver. Folat metabolites enter the liver - intestinal cycle.

Elimination

Folat metabolites are eliminated in urine and redundant folats excreted in the form of constant urine.

Before taking Bidiferon medicine for preventive treatment iron and folic acid (10 blisters x 10 tablets)

How to use

Bidiferon 160.2 mg orally. Drink whole tablets with lots of water. Do not chew or suck in the mouth. It is best to drink before meals, but can be adjusted according to the gastrointestinal tolerance.

Dosage

One tablet per day (equivalent to 50 mg of elemental iron and 0.35 mg of folic acid) in the last 2 months of pregnancy (or from the 4th month of pregnancy).

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when overdose?

Overdose

Cases of overdose of iron salt have been recorded, especially in children due to accidentally swallowed. Symptoms include irritation and gastrointestinal necrosis that leads to abdominal pain, half vomiting, bleeding diarrhea, acute renal failure, liver failure, and convulsions.

How to handle overdose drugs

It is necessary to treat as soon as possible, carry out the stomach with 1%sodium bicarbonate solution.

Depending on the serum iron concentration, the use of chelate may be recommended, especially when using Deferoxamin. If necessary, please refer to Deferoxamin's product information.

In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

What to do when forgetting a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Do not drink twice as prescribed.

Side Effects

When using Bidiferon 160.2 mg Bidiphar 10x10, you may experience unwanted effects (ADR).

related to iron

Common, 1/100

  • Digestive disorders: constipation, diarrhea, abdominal stretch, abdominal pain, discoloration, nausea.
  • Rare, 1/1000

  • Intermediate, chest and respiratory disorders: laryngeal edema.
  • Gastrointestinal disorders: abnormal stools, indigestion, vomiting, gastritis.

    Unknown (not evaluated from existing data)

  • Immune system disorders: Hypersensitivity, rash.
  • Gastrointestinal disorders: Dental hygiene (*), mouth ulcer (*), Stomach melanoma.
  • Skin and tissue disorders: itching, rash.

    (*) In the case of chewing or sucking tablets in the mouth.

    From post -commercial data, the following side effects have been reported with unknown frequency.

    Hypersensitivity, urticaria, dental disorders *, mouth ulcers * and gastrointestinal melanoma have been reported with unknown frequencies (see above).

    Patients with elderly people and patients with disorders may be prone to esophageal or bronchial necrosis in the case of swallowing the wrong way.

    Other special cases

    According to existing data, the pigmentation of the gastrointestinal mucosa (post -death hemoglobin/melanoma) has been observed in patients with iron supplements. This pigment can interfere with stomach -intestinal surgery (see warning and caution).

    related to folic acid

    unknown (not evaluated from existing data)

  • Immune system disorders: Anaphylactic reaction.
  • Gastrointestinal disorders: digestive disorders.

    Skin and subcutaneous tissue disorders: edema, atopic dermatitis, urticaria.

    Instructions on how to handle ADR

    Can limit the ADR often by taking low doses, then increasing, or taking a little food (thus reducing iron absorption).

    When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

    Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    Contraindicated

    Bidiferon 160.2 mg Bidiphar 10x10 contraindications in the following cases:

  • Hypersensitivity to iron, folic acid or any ingredient of the drug.
  • Overload of iron.
  • Thalassemia disease.
  • Persistent anemia.

  • Achievement of marrow failure.
  • Precautions when using

    Plasma iron deficiency is associated with inflammatory syndrome that are not sensitive to iron supplements.

    Must combine iron supplements with cause treatment.

    Due to the risk of dyeing teeth and mouth ulcers, avoid chewing or sucking in the mouth. Must swallow the whole tablet with many countries.

    According to the existing document, the pigmentation of the stomach - intestinal mucosa (post -death hemoglobin/melanoma) has been observed in patients with iron supplements.

    This pigment can interfere with stomach -intestinal surgery and therefore should be noted, especially in scheduled surgery. Therefore, it is necessary to notify the surgeon about the current iron supplementation along with this risk (see the unwanted effect section).

    Drinking plenty of tea reduces iron absorption.

    The ability to drive and operate machinery

    The drug does not affect the ability to drive and operate the machine.

    Pregnancy

    Clinical data on several thousand women treated does not show the adverse effects of sulfate iron. Therefore, under normal conditions, this drug can be used during pregnancy.

    Animal studies show that there is no impact on the fertility of both men and women.

    Breastfeeding period

    The excretion of sulfate iron into milk has not been evaluated, but based on molecular structure, preparations can be used for breastfeeding women.

    Drug interaction

    related to iron

    Coordination should not be used

    iron (salt) (oral): causes fainting, even shocked by the rapid release of iron from the complex form and by Siderophilin saturation.

    Coordination should be considered

    acetohydroxamic acid: Reduce the absorption of the gastrointestinal tract of these two drugs due to iron chelate.

    Cautious coordination when using

    biphosphonate (oral): reduces the absorption of diphosphonate. Use these drugs from at least 30 minutes to more than 2 hours if possible.

    calcium: Reduce the absorption of the digestive tract of iron salt. Use iron salt away from meals and without calcium.

    Cyclin (oral): Reduce the absorption of cyclin due to forming a complex. Use these drugs at least 2 hours apart.

    Entecapon: Reducing the absorption of Entecapon and iron due to the chelate of Entacapon. Use these drugs at least 2 hours apart.

    fluoroquinolon: iron reduces the absorption of fluoroquinolon. Using these drugs should be at least 2 hours apart.

    thyroid hormone: reduces the absorption of thyroid hormone. Use these drugs at least 2 hours apart.

    Levodopa/Carbidopa: Reduce the absorption of Levodopa/Carbidopa. Use these drugs at least 2 hours apart.

    methyldopa: Reducing methyldopa absorption due to a complex formation. Use these drugs at least 2 hours apart.

    penicilamin: reduces the absorption of penicilamin. Use these drugs at least 2 hours apart.

    Strontium: Reducing the absorption of Strontium. Use these drugs at least 2 hours apart.

    Zinc: Reduce the absorption of zinc. Use these drugs at least 2 hours apart.

    Salt, oxyd, hydroxyd of Mg, Al, Ca (covering the stomach lining): Reducing the absorption of the digestive tract of iron salts. Use these drugs 2 hours apart.

    cholestyramin: Reduce iron absorption. Use iron before using cholestyramin 1 - 2 hours or after using Cholestyramin 4 hours.

    Other types of interactions: Phytic acid (whole grain), beans, polyphenols (tea, coffee, red wine), calcium (milk, dairy products) and some proteins (eggs) significantly inhibit the absorption of iron. Use iron away from these foods at least 2 hours.

    related to folic acid

    Phenobarbital, primidon, phenytoin, fosphenytoin: Reduce plasma concentrations of anti -convulsions by increasing liver specialization, in which folic acid is thought to be one of the co -factors. Clinically monitor, control the concentration of anti -convulsions in plasma and, when appropriate, adjust the anti -epileptic dose while supplementing and after folic stops.

    Cavalry of the drug: has not found the drug's information.

    Storage

    In a dry place, the temperature does not exceed 30 ° C, avoiding light.

    Expiry date: 36 months from the date of production.

    Do not use overdue drugs indicated on the packaging.

    Manufacturer: Pharmaceutical Joint Stock Company - TTBYT Binh Dinh (Bidiphar).

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords